Amesite Stock Price, News & Analysis
Company Description
Amesite Inc. (NASDAQ: AMST) is an AI-driven technology company that develops and markets B2B and B2C artificial intelligence-powered software, with a primary focus on the home health and broader healthcare segments. According to company disclosures, Amesite positions its technology to support healthcare workers and organizations by improving documentation, communication, and operational efficiency. While historically described as an AI-driven platform and course designer for schools and businesses, more recent information emphasizes its strategy to serve the home and healthcare markets.
The company’s flagship product is NurseMagic™, an AI-powered application designed to streamline documentation for nurses, caregivers, and other healthcare professionals. Amesite states that NurseMagic™ reduces the time required for documentation from 20 minutes to about 20 seconds, and that it is used by over 100 professions to improve care, enhance operational efficiency, and support financial performance. The platform is built on proprietary AI trained on industry-specific data and is described as meeting HIPAA requirements, enabling healthcare workers to handle protected health information within a compliant environment.
Core Products and Solutions
Amesite’s business centers on delivering AI-powered enterprise and consumer solutions through the NurseMagic™ platform. The company reports that it serves both B2B customers, such as agencies and corporations in home health care, skilled nursing, hospice, and related segments, and B2C users, including individual healthcare professionals who subscribe directly.
Key elements of the NurseMagic™ offering, as described in company communications, include:
- AI-powered charting and documentation for nurses and caregivers, aimed at reducing documentation time and supporting audit-ready records.
- HIPAA-compliant usage for both enterprise and individual users, supported by Business Associate Agreements (BAAs) and workflows designed for handling sensitive health information.
- Multilingual charting capabilities, with NurseMagic™ V3.0 supporting documentation in 16 languages, targeting English-as-a-second-language nurses in the U.S. and multilingual healthcare environments.
- Enterprise-focused tiers, such as Teams Plus+ and NurseMagic™ Enterprise, which are described as addressing higher-intensity usage, team analytics, and large-scale deployment needs.
- Support for clinical and non-clinical roles, including nurses, CNAs, aides, chaplains, social workers, coordinators, and other healthcare support workers.
NurseMagic™ Enterprise and EMR Capabilities
Amesite reports that it has expanded NurseMagic™ into an enterprise-grade platform for post-acute healthcare providers. The NurseMagic™ Enterprise tier is described as integrating advanced AI capabilities into existing workflows for mid- and large-scale post-acute providers, with pricing aligned to patient census rather than staff headcount. According to company announcements, this model is intended to support deployment across entire care teams and to scale revenue in step with patient volumes.
The company highlights several capabilities within NurseMagic™ Enterprise:
- EMR integration, enabling bi-directional data transfer with electronic medical records so that documentation created in NurseMagic™ can populate clinical systems.
- Automated interdisciplinary team (IDT) reporting, generating formatted reports to address compliance processes for home health and hospice agencies.
- Custom-formatted documentation to align with payer, regulatory, and internal templates, supporting billing and compliance requirements.
- Census-based pricing, tying platform costs to patient census to allow organizations with lean teams and large patient loads to deploy the solution across full care teams.
In later disclosures, Amesite announced the launch of NurseMagic™ EMR, described as an AI-native, modular electronic medical record solution for post-acute care. The company states that this EMR extends NurseMagic™ from a point-of-care solution into core post-acute care infrastructure, supporting coexistence with legacy systems or full system replacement. This development reflects Amesite’s stated aim to provide infrastructure-level tools for post-acute organizations.
Market Focus and Customer Segments
Amesite identifies the home health, hospice, skilled nursing, senior living, and home care markets as key segments for NurseMagic™. Company communications note a focus on post-acute healthcare providers across the United States, and describe usage of NurseMagic™ across all 50 U.S. states and in multiple countries. Amesite also reports that its sales efforts target both clinical and non-clinical staff within agencies and corporations, including large hospice providers and other organizations in the post-acute ecosystem.
The company has stated that its addressable market expanded as it introduced tools for non-clinical caregivers and support workers, and as it launched higher-priced tiers such as Teams Plus+ and Enterprise. Amesite’s disclosures emphasize that customers have adopted NurseMagic™ across entire teams, and that enterprise clients use the platform for real-time insights, productivity metrics, and documentation support.
Regulatory and Compliance Context
Amesite highlights regulatory compliance as a central feature of its healthcare offerings. The company states that NurseMagic™ meets HIPAA requirements for both enterprise and individual users, enabling safe handling of protected health information. It also describes solutions designed to address regulatory documentation requirements, such as automated form-fill capabilities for government forms and tools intended to support compliant, reimbursable submissions in connection with evolving assessment standards for hospice and other post-acute providers.
From a corporate regulatory perspective, Amesite files reports with the U.S. Securities and Exchange Commission (SEC) as a Nasdaq-listed issuer. In an 8-K filing dated October 28, 2025, the company reported receiving a notice from The Nasdaq Stock Market LLC indicating non-compliance with certain continued listing standards related to stockholders’ equity and alternative listing criteria. Amesite stated its intention to submit a plan to regain compliance and noted that the notice did not have an immediate effect on the listing or trading of its common stock on the Nasdaq Capital Market under the symbol AMST.
Corporate Status and Exchange Listing
According to recent SEC filings, Amesite’s common stock, with a par value of $0.0001 per share, is listed on The Nasdaq Stock Market LLC under the trading symbol AMST. The company has identified itself as an emerging growth company under applicable SEC rules. While it has disclosed challenges related to Nasdaq listing standards and internal control weaknesses in prior periods, the filings do not state that the company has been delisted or that trading has ceased. Instead, they describe processes and timelines for potential remediation and continued listing.
Evolution from Education to Healthcare
Earlier descriptions of Amesite characterized it as an artificial intelligence-driven platform and course designer that provided customized online products for schools and businesses, helping educational institutions and enterprises improve learning. The company’s more recent public communications, however, emphasize its role as a developer of AI-powered enterprise solutions in healthcare, particularly post-acute care. This suggests an evolution in focus from education technology toward healthcare documentation and workflow support, though both descriptions identify AI as the core enabling technology.
Business Model Overview
Based on the company’s statements, Amesite’s business model centers on subscription-based access to its AI-powered NurseMagic™ platform for both organizations and individual users. It offers multiple tiers tailored to different levels of usage and organizational scale, including individual subscriptions, team-oriented plans, and enterprise tiers with integration and analytics capabilities. The company emphasizes recurring revenue from B2B and B2C customers, and reports that revenue growth has been associated with the introduction and expansion of higher-value tiers and enterprise offerings.
Risk and Considerations
Investors reviewing Amesite should consider the information disclosed in its SEC filings, including notices regarding Nasdaq listing compliance and prior disclosures about internal control weaknesses over financial reporting. These filings provide context on regulatory, financial reporting, and listing-related risks. As with any emerging growth company operating in regulated healthcare and technology markets, outcomes depend on continued adoption of its products, regulatory developments, and the company’s ability to address any identified compliance or control issues.
Summary
In summary, Amesite Inc. is an AI-focused technology company whose current public materials highlight its efforts to support the home and healthcare sectors through the NurseMagic™ platform. With features such as AI-powered documentation, multilingual support, HIPAA-compliant workflows, enterprise integration, and an AI-native EMR for post-acute care, Amesite presents itself as a provider of tools intended to help healthcare organizations and professionals manage documentation and operational demands. Its shares trade on Nasdaq under the symbol AMST, and its regulatory and financial disclosures are available through its SEC filings.